The information provided by the SphygmoCor System is relevant in many varying applications in the area of clinical diagnosis and treatment. Through the evaluation of arterial stiffness and its impact on the heart, clinicians have an increased ability to assess disease progression and patient risk.

The major areas in which this system can be applied include the following:

Hypertension – the SphygmoCor system provides a comprehensive cardiovascular assessment, thereby allowing more effective treatment and patient management decisions.

Heart Failure – SphygmoCor provides the ability to differentiate between primarily systolic and primarily diastolic heart failure, and management of the progression of diastolic dysfunction.

Renal Disease - Measures of arterial stiffness, such as those provided by the SphygmoCor have been shown to be powerful independent predictors of mortality in end-stage renal disease.

Diabetes – SphygmoCor allows improved patient treatment in diabetes due to early identification of “at risk” diabetes patients.